科赫勒斯生物科學CHRS
那斯達克 · USD
1.34
-0.03
(-2.19%)
盤中 09/09 11:28 (UTC+8)
09/09 11:28 (UTC+8)
科赫勒斯生物科學CHRS
1.34
-0.03
(-2.19%)
財務數據
損益表
- 0.77
- 1.40
- 0.71
- 2.48
- 0.08
- 0.10
- 0.12
- 0.13
- 0.12
- 0.14
- -15.80
- 81.32
- -49.35
- 250.84
- -85.97
- 34.94
- 12.84
- 10.17
- -3.44
- 16.22
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 14,307 | 12,310 | 12,748 | 11,571 | 10,254 | 7,599 | 248,304 | 70,774 | 139,734 | 77,063 |
營業成本 | 4,242 | 3,814 | 4,045 | 3,721 | 3,395 | 2,653 | 111,576 | 20,741 | 61,515 | 34,586 |
營業毛利 | 10,065 | 8,496 | 8,703 | 7,850 | 6,859 | 4,946 | 136,728 | 50,033 | 78,219 | 42,477 |
營業費用 | 42,396 | 44,647 | 54,583 | 52,183 | 52,345 | - | 94,126 | 56,420 | - | - |
研發費用 | 21,442 | 21,543 | 30,974 | 27,252 | 26,306 | 24,356 | 22,262 | 21,676 | 22,001 | 28,470 |
推銷及管理費用 | 20,954 | 23,104 | 23,609 | 24,931 | 26,039 | 26,025 | 71,864 | 34,744 | 51,465 | 56,532 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -32,331 | -36,151 | -45,880 | -44,333 | -45,486 | -45,435 | 42,602 | -6,387 | 4,753 | -42,525 |
其他收入及費用 | 1,307 | 1,402 | 1,782 | 2,141 | 2,901 | 187 | 173,542 | 998 | 166,569 | 156,516 |
利息費用 | 2,323 | 2,186 | 2,249 | 2,325 | 2,277 | 2,150 | 18,336 | 5,362 | 13,332 | 11,116 |
稅前純益 | -33,347 | -36,935 | -46,347 | -44,517 | -44,862 | -47,398 | 197,808 | -10,751 | 157,990 | 102,875 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -20,631 | -38,327 | -37,643 | -35,531 | 297,767 | -56,569 | -50,696 | -10,751 | -12,921 | 102,875 |
基本每股稅後盈餘(元) | -0.13 | -0.28 | -0.31 | -0.31 | 2.57 | -0.49 | -0.44 | -0.09 | -0.11 | 0.91 |
稀釋每股稅後盈餘(元) | -0.12 | -0.28 | -0.34 | -0.31 | 2.57 | -0.49 | -0.44 | -0.10 | -0.12 | 0.91 |
基本平均股數(千股) | 154816.00 | 136398.00 | 120369.00 | 116229.00 | 116077.00 | 115857.00 | 115418.00 | 115210.00 | 114819.00 | 112749.00 |
稀釋平均股數(千股) | 154816.00 | 136398.00 | 120369.00 | 116229.00 | 116077.00 | 115857.00 | 115418.00 | 115210.00 | 114819.00 | 112749.00 |
還原基本每股稅後盈餘(元) | -0.13 | -0.28 | -0.31 | -0.31 | 2.57 | -0.49 | -0.44 | -0.09 | -0.11 | 0.91 |
還原稀釋每股稅後盈餘(元) | -0.12 | -0.28 | -0.34 | -0.31 | 2.57 | -0.49 | -0.44 | -0.10 | -0.12 | 0.91 |
還原基本平均股數(千股) | 154,816 | 136,398 | 120,369 | 116,229 | 116,077 | 115,857 | 115,418 | 115,210 | 114,819 | 112,749 |
還原稀釋平均股數(千股) | 154,816 | 136,398 | 120,369 | 116,229 | 116,077 | 115,857 | 115,418 | 115,210 | 114,819 | 112,749 |
EBITDA(千元) | -17,446 | -35,260 | -34,498 | -32,240 | 301,060 | -53,373 | -27,168 | -3,840 | 1,598 | 115,498 |